Abstract:The chemoenzymatic synthesis of heparin, through a multienzyme process, represents a critical challenge in providing a safe and effective substitute for this animal-sourced anticoagulant drug. D-glucuronyl C5-epimerase (C5-epi) is an enzyme acting on a heparin precursor, N-sulfoheparosan, catalyzing the reversible epimerization of D-glucuronic acid (GlcA) to L-iduronic acid (IdoA). The absence of reliable assays for C5-epi has limited elucidation of the enzymatic reaction and kinetic mechanisms. Real time and offline assays are described that rely on 1D 1HNMR to study the activity of C5-epi. Apparent steady-state kinetic parameters for both the forward and the pseudo-reverse reactions of C5-epi are determined for the first time using polysaccharide substrates directly relevant to the chemoenzymatic synthesis and biosynthesis of heparin. The forward reaction shows unusual sigmoidal kinetic behavior, and the pseudo-reverse reaction displays nonsaturating kinetic behavior. The atypical sigmoidal behavior of the forward reaction was probed using a range of buffer additives. Surprisingly, the addition of 25 mM each of CaCl2 and MgCl2 resulted in a forward reaction exhibiting more conventional Michaelis-Menten kinetics. The addition of 2-O-sulfotransferase, the next enzyme involved in heparin synthesis, in the absence of 3'-phosphoadenosine 5'-phosphosulfate, also resulted in C5-epi exhibiting a more conventional Michaelis-Menten kinetic behavior in the forward reaction accompanied by a significant increase in apparent V-max. This study provides critical information for understanding the reaction kinetics of C5-epi, which may result in improved methods for the chemoenzymatic synthesis of bioengineered heparin.

Polysaccharide Sequence Influences the Specificity and Catalytic Activity of Glucuronyl C5-Epimerase.

Elucidating the Unusual Reaction Kinetics of D-glucuronyl C5-epimerase

Capsule Treatment by Soluble Expressed Recombinant Heparinase II Enhance the Foreign Gene Transformation to Escherichia coli K5

Immobilized Enzymes to Convert N-sulfo, N-acetyl Heparosan to a Critical Intermediate in the Production of Bioengineered Heparin

Heparinase 1 Selectivity For The 3,6-Di-O-Sulfo-2-Deoxy-2-Sulfamido-Alpha-D-Glucopyranose (1,4) 2-O-Sulfo-Alpha-L-Idopyranosyluronic Acid (Glcns3s6s-Idoa2s) Linkages

Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido- -D-glucopyranose (1,4) 2-O-sulfo- -L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages

Control of the Heparosan N-deacetylation Leads to an Improved Bioengineered Heparin

High Cell Density Cultivation of Recombinant Escherichia coli Strains Expressing 2- O -Sulfotransferase and C5-Epimerase for the Production of Bioengineered Heparin

Expression and secretion of glycosylated heparin biosynthetic enzymes using Komagataella pastoris

Specificity and Action Pattern of Heparanase Bp, a Β-Glucuronidase from Burkholderia Pseudomallei

Enzymatic access to the rare ΔUA (1→4) Glc 3, 6, N-sulfated heparin disaccharide, implications for heparin quality control

Probing cleavage promiscuity of heparinase III towards chemoenzymatically synthetic heparan sulfate oligosaccharides.

Interacting polymer-modification enzymes in heparan sulfate biosynthesis

E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor

Structure-based engineering of heparinase I with improved specific activity for degrading heparin

CHAPTER 8. Chemoenzymatic Synthesis of Low-Molecular-Weight Heparin and Heparan Sulfate

Uncovering Biphasic Catalytic Mode of C 5 -Epimerase in Heparan Sulfate Biosynthesis

Biosynthetic production of anticoagulant heparin polysaccharides through metabolic and sulfotransferases engineering strategies

Combinatorial One-Pot Chemoenzymatic Synthesis of Heparin.

A Purification Process for Heparin and Precursor Polysaccharides Using the Ph Responsive Behavior of Chitosan.

Using Engineered 6-O-sulfotransferase to Improve the Synthesis of Anticoagulant Heparin